Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 1631 entries
View as:

Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern

Phase: N/A Priority: Normal
NCT ID: NCT03493295 Org: User:
Start: 04/25/18 End: 03/15/21 Due: 03/15/22

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Phase: N/A Priority: Normal
NCT ID: NCT04142437 Org: User:
Start: 04/03/20 End: 03/31/30 Due: 03/31/31

Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02957396 Org: User:
Start: 11/17/16 End: 03/01/17 Due: 03/01/18

A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering

Phase: N/A Priority: Normal
NCT ID: NCT03853538 Org: User:
Start: 01/28/19 End: 03/06/19 Due: 03/06/20

PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.

Phase: N/A Priority: Normal
NCT ID: NCT03901131 Org: User:
Start: 08/26/19 End: 02/17/22 Due: 02/17/23

An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT03799016 Org: User:
Start: 12/15/16 End: 07/01/17 Due: 07/01/18

Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II

Phase: N/A Priority: Normal
NCT ID: NCT00377793 Org: User:
Start: 07/31/06 End: 08/31/07 Due: 08/31/08

Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Phase: N/A Priority: Normal
NCT ID: NCT02106832 Org: User:
Start: 04/30/14 End: 10/19/16 Due: 10/19/17

Sun Protection Factor Assay (SPF Assay 199/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02930746 Org: User:
Start: 10/12/16 End: 10/13/16 Due: 10/13/17

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT01933152 Org: User:
Start: 08/31/12 End: 04/30/13 Due: 04/30/14

Regorafenib Phase I Study in Mainland Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT02398513 Org: User:
Start: 04/30/15 End: 06/30/16 Due: 06/30/17

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

Phase: N/A Priority: Normal
NCT ID: NCT02470767 Org: User:
Start: 05/31/15 End: 03/31/16 Due: 03/31/17

A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)

Phase: N/A Priority: Normal
NCT ID: NCT05532046 Org: User:
Start: 09/20/22 End: 03/31/23 Due: 03/31/24

A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Phase: N/A Priority: Normal
NCT ID: NCT06562985 Org: User:
Start: 09/18/24 End: 01/06/25 Due: 01/06/26

Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00672113 Org: User:
Start: 12/31/03 End: 08/31/04 Due: 08/31/05

Xarelto [SPAF] Post-marketing Surveillance in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01582737 Org: User:
Start: 05/30/12 End: 01/17/20 Due: 01/17/21

18612 - Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02760576 Org: User:
Start: 10/14/15 End: 10/16/15 Due: 10/16/16

A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05149131 Org: User:
Start: 01/17/22 End: 08/16/22 Due: 08/16/23

Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00993109 Org: User:
Start: 02/28/10 End: 05/31/11 Due: 05/31/12

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

Phase: N/A Priority: Normal
NCT ID: NCT01073540 Org: User:
Start: 09/30/09 End: 09/30/09 Due: 09/30/10

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT01442792 Org: User:
Start: 10/12/11 End: 03/04/13 Due: 03/04/14

Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00431678 Org: User:
Start: 01/31/04 End: 07/31/05 Due: 07/31/06

Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy

Phase: N/A Priority: Normal
NCT ID: NCT01539681 Org: User:
Start: 02/29/12 End: 02/28/15 Due: 02/28/16

Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT04264637 Org: User:
Start: 02/03/20 End: 03/17/21 Due: 03/17/22

Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs

Phase: N/A Priority: Normal
NCT ID: NCT03863990 Org: User:
Start: 07/15/19 End: 05/11/20 Due: 05/11/21